Author:
Berezutsky M. A.,Durnova N. A.,Sheremetyewa A. S.,Matvienko U. A.,Kurchatova M. N.
Subject
Geriatrics and Gerontology,Gerontology
Reference56 articles.
1. Anisimov, S.V., Cell therapy of Parkinson’s disease: IV. Risks and prospects, Usp. Gerontol., 2009, vol. 22, no. 3, pp. 418–439.
2. Berezutskii, M.A., Durnova, N.A., and Vlasova, Ya.A., Experimental and clinical studies of mechanisms of the antiaging effects of chemical compounds in Astragalus membranaceus (review), Adv. Gerontol., 2020, vol. 10, no. 2, pp. 142–149.
3. Lesnyak, O.M. and Benevolenskaya, L.I., Osteoporosis in the Russian Federation: problems and prospects, Nauchno-Prakt. Revmatol., 2010, no. 5, pp. 14–18.
4. Maximov, V.N., Malyutina, S.K., Orlov, P.S., et al., Leukocyte telomere length as an aging marker and risk factor for human age-related diseases, Adv. Gerontol., 2017, vol. 7, no. 2, pp. 101–106.
5. Oleshko, O.S., Cheresiz, S.V., and Pokrovskii, A.G., Induction of expression of osteoclast-specific genes by cytokines in human monocytes, Vestn. NGU (Ser.: Biol. Clin. Med.), 2012, vol. 10, no. 3, pp. 5–10.